EMEA

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market, with an emphasis on the European region. Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development. Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Join us for this two day in person event for industry leading updates on a series of topics around temperature-controlled logistics. This will include how to avoid excursions, using data to monitor temperatures, shipping products at deep frozen temperatures and how your peers are coping with new Brexit regulations affecting the supply chain in and out of the 

With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access.  Topics are curated to addresses the biggest bottlenecks in cell and gene therapy development.

Gather fresh insights into regulatory updates, trial-running techniques for small companies, and the latest innovations. With presentations and panel discussions on industry trends and outsourcing challenges, this 2-day event is a must-attend for the European medical device and diagnostics community. Network with industry peers, collaborate with trial sponsors, manufacturers, and vendors, and tackle post-MDR challenges together.

This European clinical show will provide delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials.

This event will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over two days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs and constructing defined deadlines.

This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining our OCT, CTS and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about latest developments.

A thorough 2 day event addressing emerging strategies for the drug development of Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases. This in-depth event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing.

Connecting global pharma, biotech and academia for high-level discussions on the latest innovations in biologics development. Consisting of the Proteins & Antibodies Congress, Bispecifics in Discovery & Development Congress and Peptides & Oligonucleotides Congress, visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the biologics industry in the future.

Summit for Clinical Trials Operations Executives Europe is a two-day event serving clin ops execs, functional heads, category managers and those responsible for the planning and management of clinical trials. Leaders from large and small pharma,
specialty pharma, biotech, and academic research come together to share best practices and discuss the new era of analytics-driven, patient-centric trials.